Universitätsklinikum Heidelberg

Treatment patterns in geriatric patients with melanoma and the effect of age on the efficacy of immunotherapy: Analysis from the real-world multicenter registry ADOREG (2026) Lallas K, Nanz L, Ugurel S, Mohr P, Meier F, Weichenthal M, von Wasielewski I, et al. Journal article Resistance to anti-PD-1 immunotherapy for stage III and IV melanoma: a global chart review study (2026) Gaughan EM, Kim M, Mendez I, Rao AD, Wei M, So A, Zhong X, et al. Journal article Immune checkpoint inhibitor-associated myocarditis: A novel risk score (2026) Power JR, Dolladille C, Ozbay B, Procureur A, Ederhy S, Palaskas NL, Lehmann LH, et al. Journal article External quality assessment in antimicrobial susceptibility testing (EUCAST disc diffusion methodology) of five anaerobic strains – performance of 35 laboratories in Germany and Austria, 2024 (2026) Buhl M, Jung J, Stingu CS, Copsey-Mawer S, Held J, Haase G, Sieg M, et al. Journal article Advances in automated fetal brain MRI segmentation and biometry: Insights from the FeTA 2024 challenge (2026) Zalevskyi V, Sanchez T, Kaandorp M, Roulet M, Fajardo-Rojas D, Li L, Hutter J, et al. Journal article Radiobiology Contributions and Perspectives in Hadron Therapy, With a Focus on Carbon Ions: Report From the Workshop Hadron Therapy for Life, Caen, March 2025 (2026) Haghdoost S, Thariat J, Toma-Dasu I, Frey B, Rodriguez-Lafrasse C, Valable S, Laurent C, et al. Journal article Loss-of-function variants in the CAPN1 activator CD99L2 cause X-linked spastic ataxia (2026) Menden B, Incebacak Eltemur RD, Demidov G, Sturm M, Park J, Huridou C, Fath F, et al. Journal article Advancing CNS tumor diagnostics with expanded DNA methylation-based classification (2026) Sill M, Schrimpf D, Patel A, Sturm D, Jäger N, Sievers P, Schweizer L, et al. Journal article Developing an advanced risk stratification model for pediatric intracranial ependymoma based on the prospective trial E-HIT2000 and subsequent registries (2026) Von Hoff K, Obrecht-Sturm D, Ghasemi DR, Wenning J, Mynarek M, Gerber NU, Benesch M, et al. Journal article COMBI-EU: Real-World Evidence on Adverse Event Management and Time on Therapy with Adjuvant Dabrafenib Plus Trametinib in Patients with BRAF V600-Mutant Melanoma (2026) Weichenthal M, Debus D, Zimmer L, Wasielewski Iv, Meier F, Tüting T, Heppt M, et al. Journal article